Thus, TRAF6-induced NF-κB activation within the RANK and toll-like receptor (TLR) pathways is significantly implicated in the advancement and maintenance of cancer cells, particularly in cancers prone to bone metastasis, including breast 9, prostate 10, lung 11, and liver cancers 12. Here, TRAF6 is linked to cancer.